Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,352 | 414 | 99.8% |
| Education | $13.60 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $771.32 | 57 | $0 (2024) |
| Novo Nordisk Inc | $640.40 | 49 | $0 (2024) |
| Amgen Inc. | $603.65 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $450.82 | 20 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $437.72 | 24 | $0 (2021) |
| PFIZER INC. | $375.62 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $292.60 | 18 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $281.28 | 18 | $0 (2023) |
| Lilly USA, LLC | $231.35 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $220.33 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $910.78 | 52 | ABBVIE INC. ($148.70) |
| 2023 | $641.83 | 37 | ABBVIE INC. ($240.02) |
| 2022 | $755.21 | 42 | ABBVIE INC. ($174.50) |
| 2021 | $251.03 | 20 | AbbVie Inc. ($112.14) |
| 2020 | $713.66 | 42 | SANOFI-AVENTIS U.S. LLC ($142.09) |
| 2019 | $1,413 | 101 | Amgen Inc. ($175.28) |
| 2018 | $1,480 | 108 | Amgen Inc. ($236.72) |
| 2017 | $200.11 | 13 | Supernus Pharmaceuticals, Inc. ($59.38) |
All Payment Transactions
415 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PAIN | ||||||
| 12/02/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Hematology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Endocrinology | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Obesity | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: DIABETES | ||||||
| 07/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Inflammation | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardio-renal | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Respiratory | ||||||
| 06/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,450 | 3,080 | $433,421 | $153,140 |
| 2022 | 19 | 1,404 | 2,274 | $304,085 | $108,133 |
| 2021 | 19 | 1,207 | 1,770 | $238,211 | $92,019 |
| 2020 | 18 | 1,091 | 1,586 | $219,948 | $74,581 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 428 | $108,748 | $35,124 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 254 | 483 | $83,468 | $28,157 | 33.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 93 | 743 | $87,035 | $26,383 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 190 | 190 | $46,493 | $23,342 | 50.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 87 | 325 | $31,626 | $11,465 | 36.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 81 | 82 | $8,087 | $6,211 | 76.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 39 | 108 | $8,551 | $3,199 | 37.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 15 | $9,165 | $3,160 | 34.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $7,794 | $2,799 | 35.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 74 | $7,588 | $2,787 | 36.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 87 | 88 | $4,576 | $2,567 | 56.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,846 | $1,743 | 45.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 12 | 12 | $2,510 | $1,677 | 66.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,100 | $1,151 | 22.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 104 | $6,240 | $1,053 | 16.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 12 | $1,764 | $652.11 | 37.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 38 | 45 | $2,700 | $428.40 | 15.9% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 29 | 29 | $1,031 | $361.59 | 35.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,112 | $346.93 | 16.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $1,827 | $207.86 | 11.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 49 | 65 | $845.00 | $143.00 | 16.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 122 | $1,220 | $96.84 | 7.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 73 | $1,095 | $87.73 | 8.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 372 | $94,860 | $29,203 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 459 | $79,407 | $26,562 | 33.4% |
About Dr. Ailisa Smith, MD
Dr. Ailisa Smith, MD is a Family Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356479828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ailisa Smith, MD has received a total of $6,366 in payments from pharmaceutical and medical device companies, with $910.78 received in 2024. These payments were reported across 415 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,352).
As a Medicare-enrolled provider, Smith has provided services to 5,152 Medicare beneficiaries, totaling 8,710 services with total Medicare billing of $427,873. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Legal Medicine
- Location Hickory, NC
- Active Since 02/28/2007
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356479828
Products in Payments
- VRAYLAR (Drug) $378.26
- OXTELLAR XR (Drug) $344.09
- Aimovig (Biological) $285.45
- Ozempic (Drug) $224.68
- TRELEGY ELLIPTA (Drug) $221.48
- XIFAXAN (Drug) $201.98
- NURTEC ODT (Drug) $178.83
- SOLIQUA 100/33 (Biological) $168.68
- Saxenda (Drug) $165.94
- Tymlos (Biological) $156.75
- Repatha (Biological) $136.45
- JANUVIA (Drug) $135.55
- LINZESS (Drug) $119.48
- Kerendia (Drug) $117.84
- FARXIGA (Drug) $116.43
- CHANTIX (Drug) $116.05
- TRULICITY (Drug) $114.21
- Dexcom G6 Transmitter (Medical Supply) $110.66
- UBRELVY (Drug) $105.39
- QULIPTA (Drug) $102.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hickory
Jonathan Wilson, Do, DO
Family Medicine — Payments: $31,125
Dr. Michael Desantis, M.d, M.D
Family Medicine — Payments: $12,291
David Duralia, M.d, M.D
Family Medicine — Payments: $11,991
Dr. Mary Britton, M.d, M.D
Family Medicine — Payments: $8,725
Robert Lee, Md, MD
Family Medicine — Payments: $8,629
Dr. Gregory Brooks, Md, MD
Family Medicine — Payments: $8,580